Tower Research Capital (TRC)’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.3K | Sell |
|
|||||
|
2025
Q2 | $106K | Buy |
|
|||||
|
2025
Q1 | $35.3K | Buy |
|
|||||
|
2024
Q4 | $36K | Buy |
|
|||||
|
2024
Q3 | $12.4K | Sell |
|
|||||
|
2024
Q2 | $75.8K | Buy |
|
|||||
|
2024
Q1 | $8.9K | Sell |
|
|||||
|
2023
Q4 | $75.9K | Sell |
|
|||||
|
2023
Q3 | $92.3K | Buy |
|
|||||
|
2023
Q2 | $28.2K | Sell |
|
|||||
|
2023
Q1 | $36K | Buy |
|
|||||
|
2022
Q4 | $16K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $11K | Buy |
|
|||||
|
2021
Q3 | $9K | Buy |
|
|||||
|
2021
Q2 | $0 | Sell |
|
|||||
|
2021
Q1 | $15K | Sell |
|
|||||
|
2020
Q4 | $107K | Buy |
|
|||||
|
2020
Q3 | $96K | Buy |
|
|||||
|
2020
Q2 | $22K | Buy |
|